Back to Trades
Sell4
Travere Therapeutics, Inc.
TVTX
Total Value
$13.3M
Net $3.2M sold
Sales
$3.2M
2 transactions
Company Information
- Company Name
- Travere Therapeutics, Inc.
- Ticker Symbol
- TVTX
- CIK
- 0001438533
Insider Information
- Name
- Dube Eric M
- Role
- Insider
- Location
- SAN DIEGO, CA
Filing Details
- Filing Date
- Feb 3, 2026
- Transaction Date
- Jan 31, 2026
- Accession Number
- 0001763494-26-000002
- Form Type
- 4
- Net Trading Amount
- -$3.2M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jan 31, 2026 | Common Stock | 113,800 | — | Grant/Award | — |
| Feb 3, 2026 | Common Stock | 66,452 | $32.06 | Sale | $2.1M |
| Feb 3, 2026 | Common Stock | 33,635 | $32.70 | Sale | $1.1M |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jan 31, 2026 | Derivative | 303,600 | $33.09 | Grant/Award | $10.0M |
Footnotes
- (F1)Each restricted stock unit represents a contingent right to receive one share of the Common Stock of the Issuer.
- (F2)This sale was made pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.
- (F3)The weighted average sale price for the transaction reported was $32.06, and the range of prices were between $31.52 and $32.52. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
- (F4)The weighted average sale price for the transaction reported was $32.70, and the range of prices were between $32.5248 and $32.88. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
- (F5)One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 36 equal monthly installments thereafter.